The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: A naturalistic study of the North American Prodrome Longitudinal Sample

作者: Elaine F. Walker , Barbara A. Cornblatt , Jean Addington , Kristin S. Cadenhead , Tyrone D. Cannon

DOI: 10.1016/J.SCHRES.2009.07.023

关键词: Clinical trialSeverity of illnessLongitudinal studyPsychiatryRelative riskPsychologyProdromeAntipsychoticRandomized controlled trialPsychosis

摘要: A substantial number of patients who meet criteria for a prodromal syndrome first psychosis are treated with antipsychotic and/or antidepressant medications. There is suggestive evidence that both classes medication may reduce symptoms. This longitudinal study examined the relation and symptom severity at baseline 6-month follow-up. Participants met Structured Interview Prodromal Syndromes (SIPS) prodrome, were evaluated eight centers as part North American Prodrome Longitudinal Study (NAPLS). Symptom ratings (positive, negative, disorganized general) data on antipsychotics, SSRIs, other medications obtained Analyses revealed all dimensions declined in over time, but there differences magnitude decline function medication. Those never antipsychotics showed less reduction positive symptoms time. SSRIs antidepressants not linked declines severity. Consistent findings from small-sample, clinical trials, present results suggest atypical be effective reducing attenuated associated prodrome to psychotic disorders. Limitations noted, including fact it randomized trial, duration dosage 2-year follow-up available most participants. The discussed light relative risks benefits preventive interventions, cognitive therapies, importance future trials.

参考文章(22)
Scott W Woods, Alan Breier, Robert B Zipursky, Diana O Perkins, Jean Addington, Tandy J Miller, Keith A Hawkins, Eva Marquez, Stacy R Lindborg, Mauricio Tohen, Thomas H McGlashan, Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome Biological Psychiatry. ,vol. 54, pp. 453- 464 ,(2003) , 10.1016/S0006-3223(03)00321-4
Jennifer L. Callahan, Shuki J. Cohen, Daniel H. Mathalon, Tandy J. Miller, Thomas H. McGlashan, Scott W. Woods, Elizabeth M. Tully, Barbara C. Walsh, Keith A. Hawkins, Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study The British journal of psychiatry. Supplement. ,vol. 191, ,(2007) , 10.1192/BJP.191.51.S96
Stephan Ruhrmann, Andreas Bechdolf, Kai-Uwe Kühn, Michael Wagner, Frauke Schultze-Lutter, Birgit Janssen, Kurt Maurer, Heinz Häfner, Wolfgang Gaebel, Hans-Jürgen Möller, Wolfgang Maier, Joachim Klosterkötter, Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis The British journal of psychiatry. Supplement. ,vol. 191, ,(2007) , 10.1192/BJP.191.51.S88
Daqiang Sun, Lisa Phillips, Dennis Velakoulis, Alison Yung, Patrick D. McGorry, Stephen J. Wood, Theo G.M. van Erp, Paul M. Thompson, Arthur W. Toga, Tyrone D. Cannon, Christos Pantelis, Progressive brain structural changes mapped as psychosis develops in ?at risk? individuals Schizophrenia Research. ,vol. 108, pp. 85- 92 ,(2009) , 10.1016/J.SCHRES.2008.11.026
Tyrone D. Cannon, Matti O. Huttunen, Minna Dahlström, Ilkka Larmo, Pirkko Räsänen, Alo Juriloo, Antipsychotic drug treatment in the prodromal phase of schizophrenia. American Journal of Psychiatry. ,vol. 159, pp. 1230- 1232 ,(2002) , 10.1176/APPI.AJP.159.7.1230
Joachim Klosterkötter, Martin Hellmich, Eckhard M. Steinmeyer, Frauke Schultze-Lutter, Diagnosing Schizophrenia in the Initial Prodromal Phase Archives of General Psychiatry. ,vol. 58, pp. 158- 164 ,(2001) , 10.1001/ARCHPSYC.58.2.158
Barbara A. Cornblatt, Todd Lencz, Christopher W. Smith, Ruth Olsen, Andrea M. Auther, Emilie Nakayama, Martin L. Lesser, Julia Y. Tai, Manoj R. Shah, Carmel A. Foley, John M. Kane, Christoph U. Correll, Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. The Journal of Clinical Psychiatry. ,vol. 68, pp. 546- 557 ,(2007) , 10.4088/JCP.V68N0410
L PHILLIPS, P MCGORRY, H YUEN, J WARD, K DONOVAN, D KELLY, S FRANCEY, A YUNG, Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophrenia Research. ,vol. 96, pp. 25- 33 ,(2007) , 10.1016/J.SCHRES.2007.05.018
Elaine F. Walker, Adolescent Neurodevelopment and Psychopathology Current Directions in Psychological Science. ,vol. 11, pp. 24- 28 ,(2002) , 10.1111/1467-8721.00161